There have been 50 recent insider transactions recorded for Oncternal Therapeutics, Inc. (ONCT), including 34 buys and 16 sells. Total insider buying was valued at $1.01M and total insider selling at $1.35M.
Notable insiders with recent activity include Hale David F, Kisner Daniel L, Larue William R. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ONCT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-06-20 |
Hale David F |
Director |
RSU Award |
3,300 |
$8.10 |
$26.73K |
3,300 |
| 2024-06-20 |
Kisner Daniel L |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Larue William R |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Carter Michael G |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Mazanet Rosemary |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Theuer Charles |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Wills Robert James |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Desimone Jill |
Director |
RSU Award |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-04-08 |
Wills Robert James |
Director |
Informative Buy |
3,086 |
$8.96 |
$27.65K |
10,000 |
| 2024-03-28 |
Wills Robert James |
Director |
Informative Buy |
6,914 |
$8.48 |
$58.6K |
6,914 |
| 2024-02-23 |
Hale David F |
Director |
Informative Buy |
714 |
$9.04 |
$6.45K |
714 |
| 2024-02-23 |
Wills Robert James |
Director |
Informative Sell |
980 |
$9.04 |
$8.86K |
- |
| 2024-02-14 |
Breitmeyer James B |
Chief Executive Officer |
RSU Award |
6,200 |
$9.18 |
$56.92K |
6,200 |
| 2024-02-14 |
Vincent Richard G |
Chief Financial Officer |
RSU Award |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Leavitt Chase C. |
General Counsel/secretary |
RSU Award |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Yazji Salim |
Chief Medical Officer |
RSU Award |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Krishnan Rajesh |
CTO/cso |
RSU Award |
17,700 |
$9.18 |
$162.49K |
17,700 |
| 2024-01-03 |
Breitmeyer James B |
Chief Executive Officer |
Tax Withholding of RSU |
4,485 |
$0.50 |
$2.23K |
15,426 |
| 2024-01-03 |
Vincent Richard G |
Chief Financial Officer |
Tax Withholding of RSU |
8,868 |
$0.50 |
$4.4K |
140,922 |
| 2024-01-03 |
Leavitt Chase C. |
General Counsel/secretary |
Tax Withholding of RSU |
11,838 |
$0.50 |
$5.87K |
84,758 |
| 2024-01-03 |
Yazji Salim |
Chief Medical Officer |
Tax Withholding of RSU |
19,742 |
$0.50 |
$9.79K |
128,635 |
| 2024-01-03 |
Krishnan Rajesh |
Chief Technical Officer |
Tax Withholding of RSU |
11,838 |
$0.50 |
$5.87K |
44,019 |
| 2023-10-02 |
Breitmeyer James B |
Chief Executive Officer |
Return of Shares |
100,000 |
$5.76 |
$576K |
- |
| 2023-10-02 |
Vincent Richard G |
Chief Financial Officer |
Return of Shares |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Leavitt Chase C. |
General Counsel/secretary |
Return of Shares |
55,519 |
$1.94 |
$107.71K |
- |
| 2023-10-02 |
Yazji Salim |
Chief Medical Officer |
Return of Shares |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Krishnan Rajesh |
Chief Technical Officer |
Return of Shares |
220,000 |
$0.96 |
$211.2K |
- |
| 2023-07-03 |
Breitmeyer James B |
Chief Executive Officer |
Tax Withholding of RSU |
4,007 |
$0.36 |
$1.44K |
19,911 |
| 2023-07-03 |
Vincent Richard G |
Chief Financial Officer |
Tax Withholding of RSU |
7,069 |
$0.36 |
$2.54K |
149,790 |
| 2023-07-03 |
Leavitt Chase C. |
General Counsel/secretary |
Tax Withholding of RSU |
10,305 |
$0.36 |
$3.71K |
96,596 |
| 2023-07-03 |
Yazji Salim |
Chief Medical Officer |
Tax Withholding of RSU |
16,299 |
$0.36 |
$5.87K |
148,377 |
| 2023-07-03 |
Krishnan Rajesh |
Chief Technology Officer |
Tax Withholding of RSU |
10,897 |
$0.36 |
$3.92K |
55,857 |
| 2023-06-28 |
Hale David F |
Director |
RSU Award |
37,500 |
$0.36 |
$13.32K |
37,500 |
| 2023-06-28 |
Kisner Daniel L |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Larue William R |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Carter Michael G |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Mazanet Rosemary |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Theuer Charles |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Wills Robert James |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Nakanishi Xin |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Desimone Jill |
Director |
RSU Award |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-14 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
Informative Buy |
3,000 |
$0.36 |
$1.08K |
94,726 |
| 2023-06-12 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
Informative Buy |
25,000 |
$0.35 |
$8.75K |
91,726 |
| 2023-04-14 |
Yazji Salim |
Chief Medical Officer |
Informative Buy |
5,000 |
$0.30 |
$1.5K |
164,676 |
| 2023-04-14 |
Breitmeyer James B |
Chief Executive Officer |
Informative Buy |
47,750 |
$0.30 |
$14.28K |
194,294 |
| 2023-04-13 |
Vincent Richard G |
Chief Financial Officer |
Informative Buy |
30,000 |
$0.30 |
$8.96K |
156,859 |
| 2023-04-13 |
Leavitt Chase C. |
General Counsel/secretary |
Informative Buy |
10,000 |
$0.29 |
$2.9K |
106,901 |
| 2023-04-13 |
Yazji Salim |
Chief Medical Officer |
Informative Buy |
10,000 |
$0.29 |
$2.85K |
159,676 |
| 2023-04-13 |
Breitmeyer James B |
Chief Executive Officer |
Informative Buy |
100,000 |
$0.29 |
$29K |
146,544 |
| 2023-04-12 |
Leavitt Chase C. |
General Counsel/secretary |
Informative Buy |
15,000 |
$0.29 |
$4.35K |
96,901 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
